phrykt

ClearPoint Neuro, Inc. (CLPT): who owns it and who trades it

As of Nov 16, 2026, CLPT insiders reported 9 open-market sales worth $2.5M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Joseph Burnett (CEO), with $2.2M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling ClearPoint Neuro

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Funds mostly bought. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CLPT

129 funds and institutions reported CLPT shares worth $249M at the end of Q2 2026, about 47% of the company. The largest holder is BlackRock, Inc. with 8.0%.

Funds and institutions (13F) 47%Everyone else 53%

10 largest owners, by share of the company

BlackRock, Inc.8.0%
Mak Capital One LLC8.0%
Vanguard Capital Management LLC4.2%
State Street Corp2.8%
Geode Capital Management, LLC2.5%
Lane Generational LLC1.5%
UBS Group AG1.4%
Millennium Management LLC1.2%
Brown Advisory Inc1.1%
Compass Financial Management LLC1.0%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.2.38M8.02%$42.5M+14%
Mak Capital One LLC2.38M8.01%$42.4M+25%
Vanguard Capital Management LLC1.23M4.16%$22M-1%
State Street Corp816,5472.75%$14.6M+20%
Geode Capital Management, LLC749,9322.53%$13.4M+6%
Lane Generational LLC444,8311.50%$7.9M-9%
UBS Group AG428,6321.44%$7.6M-1%
Millennium Management LLC357,6761.21%$6.4M+54%
Brown Advisory Inc325,9061.10%$5.8MNo change
Compass Financial Management LLC295,6801.00%$5.3M–
Susquehanna International Group, LLP240,2820.81%$4.3M+76%
Northern Trust Corp230,9860.78%$4.1M+10%
Pier Capital, LLC222,7610.75%$4M–
Vanguard Fiduciary Trust Co213,2460.72%$3.8M+4%
Vanguard Portfolio Management LLC194,5840.66%$3.5M-32%
Tudor Investment Corp Et Al173,7590.59%$3.1M+11%
Morgan Stanley165,7860.56%$3M+28%
Two Sigma Investments, LP154,8510.52%$2.8M-27%
Bank of New York Mellon Corp151,7670.51%$2.7M+6%
Parsons Capital Management Inc148,9760.50%$2.7M-0%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CLPT insiders reported $0 of open-market purchases and $2.5M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$2.5M
9 trades, 4 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jun 29, 2026
Filed Jul 1, 2026

Purchases and sales by month

$1.6M$1.6MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jun 29, 2026Joseph BurnettCEOSale20,000$19.38$388KForm 4
Jun 17, 2026Joseph BurnettCEOSale1,843$17.94$33.1KForm 4
Jun 17, 2026Joseph BurnettCEOSale60,000$17.79$1.1MForm 4
Jun 1, 2026Timothy T. RichardsDirectorSale5,415$12.17$65.9KForm 4
May 21, 2026Matthew B. KleinDirectorSale16,000$11.59$185KForm 4
May 20, 2026Lynnette C FallonDirectorSale5,091$11.14$56.7KForm 4
Feb 25, 2026Joseph BurnettCEOSale19,951$15.17$303KForm 4
Jan 26, 2026Joseph BurnettCEOSale2,943$15.57$45.8KForm 4
Jan 9, 2026Joseph BurnettCEOSale20,000$16.12$322KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Joseph BurnettCEO and President, Director–$2.2MJun 29, 2026
Matthew B. KleinDirector–$185KMay 21, 2026
Timothy T. RichardsDirector–$65.9KJun 1, 2026
Lynnette C FallonDirector–$56.7KMay 20, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CLPT short interest

High short interest. 13.4% of CLPT shares are sold short: about 1 share in 7. Over the last 12 reports the number of shares short went down 4%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 4.29M CLPT shares were sold short, 13.4% of the shares outstanding, down 7.2% from the report before. At the average daily volume of 654,965 shares, buying them all back would take about 6.6 trading days (days to cover).

Shares short, % of all shares

13.4%May 15Oct 3017.2%

Days to cover

6.6May 15Oct 3010.7

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20264.29M13.40%-7%654,9656.6
Oct 15, 20264.63M15.17%-3%703,2036.6
Sep 30, 20264.76M15.61%+10%792,1786.0
Sep 15, 20264.33M14.19%+3%625,3186.9
Aug 31, 20264.19M13.74%-7%489,9408.6
Aug 14, 20264.50M14.74%+15%762,8495.9
Jul 31, 20263.89M12.77%+5%518,4577.5
Jul 15, 20263.70M12.46%-14%466,1077.9
Jun 30, 20264.30M14.50%-13%1.55M2.8
Jun 15, 20264.92M16.58%+4%510,2459.6
May 29, 20264.74M15.98%+6%583,1138.1
May 15, 20264.49M15.13%-9%637,5567.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

ClearPoint Neuro company events

ClearPoint Neuro filed 8 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 28, 2026.

  1. Oct 28, 2026ResultsReleased financial results. Filing
  2. Aug 3, 2026ResultsReleased financial results. Filing
  3. May 21, 2026LeadershipThe annual meeting of the stockholders of ClearPoint Neuro, Inc. was held on May 20, 2026. Filing
  4. May 13, 2026ResultsReleased financial results. Filing
  5. Mar 17, 2026ResultsReleased financial results. Filing
  6. Jan 12, 2026ResultsReleased financial results. Filing
  7. Jan 5, 2026AgreementAs previously disclosed in the Quarterly Report on Form 10-Q of ClearPoint Neuro, Inc. filed with the Securities and Exchange Commission on November 6, 2025, the Company, CALW SA LLC, as purchaser agent, and TPC Investments III LP, an affiliate of Oberland Capital Management LLC, are parties to a… Filing
  8. Nov 20, 2025DealIs incorporated by reference into this Item 1.01. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

ClearPoint Neuro financials

Famous investors that hold CLPT

2 of the 50 well-known investors we track reported holding CLPT in their latest 13F filing. The largest position is Israel Englander's, worth $3M.

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 2026241,627$3M0.0%-32%
Ken Griffin · Citadel AdvisorsQ3 202681,991$1M0.0%+68%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CLPT in the last 120 days.

FiledHolderFormStake
Nov 3, 2026BIGGER CAPITAL FUND L P13G/A5.3%
Nov 3, 2026BIGGER CAPITAL FUND L P13G/A5.3%

Questions about ClearPoint Neuro, Inc. (CLPT) stock

Who owns the most CLPT stock?

The largest reported owner of ClearPoint Neuro, Inc. (CLPT) is BlackRock, Inc., with 8.0% of the company. In total, 129 funds and institutions reported holding CLPT at the end of Q2 2026, together about 47% of the shares. See the largest owners.

Are CLPT insiders buying or selling?

In the last 12 months, CLPT insiders reported no open-market purchases and 9 sales worth $2.5M. The latest trade was on Jun 29, 2026. See every trade.

What is the short interest in CLPT?

As of Oct 30, 2026, 4.29M CLPT shares were sold short, 13.4% of the shares outstanding, down 7.2% from the report before. At the average daily volume of 654,965 shares, buying them all back would take about 6.6 trading days (days to cover). See the history.

Which famous investors hold CLPT?

2 of the 50 well-known investors we track reported CLPT in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $3M. See all holders.

Executive pay

ClearPoint Neuro's chief executive was paid a total of $2.8M for the year ended Dec 31, 2025, up 11% from $2.5M the year before. In the last 12 months, ClearPoint Neuro's executives and directors bought no stock on the open market and sold $2.5M.

Chief executive, total pay$2.8MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$2.1MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.2MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.